• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE 14 DAY; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE 14 DAY; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71940-01
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Itching Sensation (1943); Skin Irritation (2076); Burning Sensation (2146)
Event Date 11/25/2019
Event Type  Injury  
Manufacturer Narrative
At this time product has not yet been returned.An extended investigation has been performed for the reported complaint.There was no indication that the product did not meet specification.  the reported complaint is related to skin irritation or an allergic reaction to the patch adhesive of the freestyle libre sensor.  dhrs (device history review) for the freestyle libre sensor and freestyle libre sensor kit were reviewed and the dhrs showed the freestyle libre sensor and freestyle libre sensor kit passed all tests prior to release.  dose audit reports were reviewed and demonstrates the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed, including bioburden and endotoxin testing, and demonstrated that all monitoring processes continue to meet adc minimum requirements for product quality.     if the product is returned, the case will be re-opened and a physical investigation will be performed.  all pertinent information available to abbott diabetes care has been submitted.
 
Event Description
A customer reported a skin reaction with the use of the adc freestyle libre sensor and experienced "itching under the sensor and burning - sweltering on the skin".Customer had contact with an hcp who prescribed him a nasal spray, mometasone furoate sandoz (50 mg), for treatment.There was no report of death or permanent injury associated with this event.
 
Event Description
A customer reported a skin reaction with the use of the adc freestyle libre sensor and experienced "itching under the sensor and burning - sweltering on the skin".Customer had contact with an hcp who prescribed him a nasal spray, memetasone furoate sandoz (50 mg), for treatment.There was no report of death or permanent injury associated with this event.
 
Manufacturer Narrative
Visual inspection has been performed on the returned sensor patch (serial number (b)(6)) and no issues were observed.Observed the adhesive was returned.Extended investigation has also been performed.A dhr (device history review) was reviewed and verified that the unit passed all tests prior to release.Dose audit reports and environmental monitoring reports, including bioburden and endotoxin testing, were reviewed and demonstrated that all monitoring processes continue to meet requirements.No malfunction or product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 14 DAY
Type of Device
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
MDR Report Key9608018
MDR Text Key175814734
Report Number2954323-2020-00588
Device Sequence Number1
Product Code PZE
Combination Product (y/n)N
PMA/PMN Number
P160030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 04/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number71940-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/01/2019
Initial Date Manufacturer Received 12/27/2019
Initial Date FDA Received01/20/2020
Supplement Dates Manufacturer Received03/16/2020
Supplement Dates FDA Received04/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Weight59
-
-